Funding Rounds
Ochre Bio Series A (2022, $30M)
Ochre BioBiotechnology platform focused on rejuvenating transplant livers.
Summary
Stage: Series A
Raised Amount: $30.00M
Raised Date: 2022-01-01
Stage: Series A
Raised Amount: $30.00M
Raised Date: 2022-01-01
